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Abstract Recent years have witnessed a rapid
development of multi-slice computed tomography
(MSCT) technology. The number of detector rows
has increased from 4-slices to the current availability
of 64-slice and even 320-slice systems. In addition,
images are acquired with thinner slices and faster
rotation times resulting in substantially improved
image quality and diagnostic accuracy. Simulta-
neously, effective dose reduction acquisition
techniques have been developed allowing consider-
able reduction of the radiation dose. Conceivably,
these advancements may allow further expansion of
the use of MSCT beyond the visual assessment of the
presence or absence of signiﬁcant coronary artery
disease. Indeed, a particular advantage of the tech-
nique is that in addition to evaluation of the coronary
arteries it also allows assessment of cardiac structures
and function. The purpose of the current review is to
discuss several novel applications of cardiac MSCT,
including stenosis quantiﬁcation, atherosclerotic pla-
que imaging and prognostiﬁcation as well as imaging
of left ventricular function, aortic and mitral valve
anatomy using state-of-the-art technology.
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Recent years have witnessed a rapid development of
multi-slice computed tomography (MSCT) technol-
ogy. The number of detector rows has increased from
4-slices to the current availability of 64-slice and
even 320-slice systems. In addition, images are
acquired with thinner slices and faster rotation times
resulting in substantially improved image quality and
diagnostic accuracy. Simultaneously, effective dose
reduction acquisition techniques have been developed
allowing considerable reduction of the radiation dose.
Conceivably, these advancements may allow further
expansion of the use of MSCT beyond the visual
assessment of the presence or absence of signiﬁcant
coronary artery disease (CAD). Indeed, a particular
advantage of the technique is that in addition to
evaluation of the coronary arteries it also allows
assessment of cardiac structures and function. The
purpose of the current review is to discuss several
novel applications of cardiac MSCT, including ste-
nosis quantiﬁcation, atherosclerotic plaque imaging
and prognostiﬁcation as well as imaging of left
ventricular (LV) function, aortic and mitral valve
anatomy using state-of-the-art technology.
Developments in imaging of the coronary arteries
Quantiﬁcation of the degree of stenosis on MSCT
High diagnostic accuracies to detect signiﬁcant
coronary artery stenoses have been reported for
MSCT as compared to invasive coronary angiogra-
phy [1]. Of note, these data are based on visual
assessment of the degree of stenosis using in general
a cut-off of 50% luminal narrowing or more. In
contrast, no validated quantitative approach is cur-
rently available which is considered to be a major
limitation of the technique. Indeed, the opportunity to
obtain a more precise measure of the degree of
stenosis, similar to quantitative coronary angiography
(QCA), would be highly beneﬁcial in terms of
diagnostic accuracy, reproducibility and subsequent
therapeutic management decisions. However, the
limited temporal and spatial resolution of MSCT as
compared to invasive coronary angiography may
pose substantial difﬁculties. Not surprisingly, previ-
ous attempts to quantify stenosis of coronary arteries
have been disappointing [2, 3]. Leber and colleagues
recently evaluated the diagnostic accuracy of stenosis
quantiﬁcation in 59 patients who were underwent
both 64-MSCT and invasive coronary angiography
[2]. In 55 patients, all coronary artery segments (825
segments, based on a 15 segment model) could be
visualized and subsequently quantiﬁed on MSCT.
Overall, only a moderate correlation (n = 825,
r = 0.54) was observed for diameter stenosis
between measurements on MSCT and QCA. In
particular, poor diagnostic accuracy of MSCT was
observed for distal segments as compared to proximal
and mid segments of the coronary arteries. With
regard to plaque type, a tendency to overestimate the
degree of stenosis in the presence of calcium has been
identiﬁed. Finally, reproducibility appears to be
limited as well [2–4].
To some extent, better correlations may be
expected by comparing MSCT to true tomographic
atherosclerosis imaging techniques, such as intravas-
cular ultrasound (IVUS). Also, the development of
more automated algorithms with less manual inter-
ference may substantially improve accuracy and
reduce interobserver variability [5, 6]. An example
of analysis with automated quantiﬁcation software
developed at our own center is provided in Fig. 1.
Recently, Bruining and coworkers reported their
observations using automated coronary plaque mea-
surements on MSCT angiography in comparison to
IVUS in 48 patients [5]. Interestingly, the authors
demonstrated that automated lumen detection on
MSCT angiographic examinations was superior to
manual assessment of vessel contours with good
reproducibility. Nevertheless, automated quantiﬁca-
tion of MSCT systematically underestimated
coronary plaque, in line with previous investigations.
Accordingly, although the potential of automated
quantiﬁcation of stenosis is evident, further develop-
ments remain needed before these algorithms can be
used in daily clinical practice. In addition, one needs
to realize that although assessment of signiﬁcant
stenosis as compared to invasive coronary angiogra-
phy may improve by the availability of quantitative
algorithms, prediction of ischemia will remain lim-
ited. Indeed, several studies comparing MSCT
coronary angiography with functional testing
revealed a large discrepancy between techniques
[7, 8]. In line with previous comparisons with
invasive coronary angiography, many signiﬁcant
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123stenoses on MSCT did not result in ischemia on
functional testing. Moreover, Meijboom et al.
recently demonstrated that even quantitative assess-
ment resulted in poor correlation with intracoronary
fractional ﬂow reserve, conﬁrming that anatomical
assessment cannot predict the hemodynamic signif-
icance of a coronary stenosis [9]. Accordingly,
further evaluation with functional testing remains
essential for angiographically intermediate lesions
prior to referral for invasive coronary angiography
and revascularization.
Plaque imaging with MSCT
AnemergingfeatureofMSCTthatreceivesincreasing
interest is its capability to non-invasively visualize
atherosclerosis, as illustrated in Fig. 2. Despite the
development of dedicated risk assessment tools, a
large number of patients without any prior symptoms
experienceacutemyocardialinfarctionorevensudden
death [10]. These unexpected adverse cardiac events
emphasize the signiﬁcance of detection of underlying
coronaryatherosclerosis. Moreover,it appearsthat not
onlyplaqueseverityintermsofpercentagestenosisbut
alsoplaquecompositionisanimportantdeterminantof
acute coronary events. Plaques with a large necrotic
core and thin ﬁbrous cap (identiﬁed by histology)
appear to be more vulnerable to rupture and can be a
substrate for atherothrombotic events [11]. Until
recently, evaluation of potentially vulnerable lesions
was onlypossible byusing invasive modalities such as
IVUS, elastography and optical coherence tomogra-
phy. However, recent studies have demonstrated the
potential of MSCT to evaluate differences in athero-
sclerotic plaque burden and composition non-
invasively [12–14]. Indeed, an important advantage
of the technique, as compared to invasive coronary
angiography, is that it visualizes not only luminal
narrowing but also atherosclerotic plaque content.
Consequently, extensive effort is currently undertaken
to determine in more detail what observed differences
in plaque morphology on MSCT represent.
Fig. 1 Example of
automated quantiﬁcation of
the degree of stenosis using
dedicated software
(QAngio
 CT, Medis,
Leiden, the Netherlands).
Initially, segment deﬁnition
is performed using proximal
and distal markers as
illustrated in a. Automated
contour detection is
performed in longitudinal
(b) and transversal
(c) views as previously
described [6]. Finally, as
shown in d, quantiﬁcation
of stenosis is based on
differences between the
reference line (red line) and
contour diameter (yellow
line), similar to traditional
QCA
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123Brieﬂy, three different plaques types can be
distinguished by MSCT; non-calciﬁed plaque, mixed
plaque and calciﬁed plaque. Calciﬁed lesions appear
as bright white dense structures, mixed plaques
consist of non-calciﬁed and calciﬁed elements within
the same plaque and non-calciﬁed plaques have lower
density compared with the contrast-enhanced vessel
lumen but without any visible calciﬁcation. Compar-
isons with IVUS have shown that using differences in
attenuation values MSCT may indeed reliably differ-
entiate plaque conﬁgurations [14]. In a recent study,
mean MSCT density of calciﬁed plaque was
516 ± 198 Hounsﬁeld Units (HU), while the mean
density measured within non-calciﬁed plaques and
mixed plaques was 11 ± 12 and 78 ± 21 HU,
respectively [15]. Further differentiation of non-
calciﬁed plaque however may be difﬁcult. Pohle
and colleagues demonstrated signiﬁcant differences
between ‘‘lipid rich’’ (mean density of 58 ± 43 HU)
and ‘‘ﬁbrous’’ plaque (mean of 121 ± 34 HU),
although the overlap of attenuation values between
individual lesions was substantial [16]. Additionally,
external factors such as the amount of contrast, body
mass index and cardiac output also highly inﬂuence
attenuation values. As a result, detailed characteriza-
tion of non-calciﬁed plaque as stable or vulnerable is
currently not feasible based on MSCT density
measurements alone. Pundziute and colleagues
recently compared plaque composition to virtual
histology IVUS (VH IVUS) and reported a good
correlation between plaque characteristics on MSCT
and relative plaque component on VH IVUS [17].
Nevertheless, still small percentages of calcium were
observed in lesions deemed to be non-calciﬁed on
MSCT. Conversely, in plaques appearing as com-
pletely calciﬁed, ﬁbrotic or ﬁbro-fatty tissue is
frequently identiﬁed on VH IVUS as well. Possibly,
initial differentiation into calciﬁed or non-calciﬁed
may therefore be more reliable. Based on their
appearance, lesions containing calcium may then be
further differentiated into large calciﬁcation or spotty
calciﬁcations, as recently suggested [18]. Interest-
ingly, features of thin capped ﬁbroatheroma
(suggesting vulnerability) were most frequently
observed in lesions classiﬁed as mixed on MSCT.
Additionally, Lin and colleagues investigated the
relationship of anatomical MSCT variables including
plaque composition and extent with functional ische-
mia on SPECT [19]. The authors observed that mixed
plaques were an independent predictor of severely
abnormal SPECT studies. These observations suggest
that the observation of multiple mixed plaques may
possibly confer a higher risk of adverse cardiac
events. Moreover, also in retrospective studies com-
paring plaque morphology on MSCT between
patients presenting with acute coronary syndromes
Fig. 2 Evaluation of
atherosclerotic plaque with
MSCT. a A curved
multiplanar reconstruction
of the right coronary artery
(RCA), obtained by 320-
slice MSCT without
evidence of atherosclerosis.
In contrast, the curved
multiplanar reconstruction
(320-slice MSCT) of the
RCA in b shows the
presence of diffuse
atherosclerosis (arrows).
Note that both non-calciﬁed
and calciﬁed tissue can be
identiﬁed
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123and stable CAD, relative more non-calciﬁed and
mixed plaques have been identiﬁed in the former
patients [20–23]. However, no robust prospective
data are currently available to support this thesis.
At present, it is important to realize that the inferior
resolution of MSCT as compared to invasive plaque
imaging techniques remains an important limitation.
Nevertheless, novel approaches are currently under
investigation including dual-energy source MSCT and
dedicated contrast agents for improvement in plaque
characterization [24, 25]. In addition, sophisticated
algorithms to accurately determine plaque volume are
under development. Potentially, these algorithms in
combination with assessment of plaque component
mayallowMSCTtoplayaroleinthemonitoringofthe
efﬁcacy of anti-atherosclerotic interventions [26, 27].
Accordingly, although plaque imaging with MSCT
represents an intriguing aspect of the technique,
available data are scarce and limited to small single-
center studies. Prospective trials are highly needed to
determine whether detailed evaluation of atheroscle-
rosis by MSCT may indeed provide clinically relevant
information.
Evaluation of prognosis with MSCT
Since non-invasive coronary angiography with
MSCT is a relatively new technique, only limited
data are available concerning its potential prognostic
value. In contrast, evaluation of the presence and
extent of atherosclerosis by means of coronary
calcium scoring (CS) has been possible for a longer
period and a considerable amount of evidence is
currently available with this technique [28]. In a large
study by Shaw et al. CS was obtained in 10,377
asymptomatic individuals who were subsequently
followed for a median of 5 years [29]. The authors
demonstrated that CS was able to predict all-cause
mortality, independent of baseline cardiac risk fac-
tors. Recently, the 2007 ACCF/AHA expert
consensus document on CS has been published in
which a systematic review of the available literature
(n = 27,622 patients) was performed [28]. Based on
these data, the presence of any coronary artery
calcium was shown to confer a fourfold increased
risk of cardiac death or myocardial infarction
(P\0.0001) as compared to the absence of coronary
artery calciﬁcations [28]. In contrast, an event rate as
low as 0.4% was observed in patients without any
coronary artery calcium. Similar observations were
recently reported in a large registry of patients
(n = 25,253 patients), conﬁrming that an increase
in the extent of coronary artery calcium corresponds
with an elevated risk for all-cause mortality [30].
Accordingly, knowledge of CS may reﬁne traditional
risk stratiﬁcation and thus guide therapeutic decisions
by shifting patients to either a higher or lower risk
category. As a consequence, particularly patients
deemed at intermediate risk based on traditional risk
assessment may beneﬁt from this technique.
Preliminary investigations using MSCT coronary
angiography have suggested that this technique may
also provide prognostic information [31, 32]. Pun-
dziute et al. assessed the prognostic value of 16- or
64-slice MSCT in a cohort of 100 patients with
known or suspected CAD [31]. During a follow-up
period of 1 year MSCT was shown to predict the
occurrence of events independent of baseline risk
factors. In a larger study by Min et al., 1,127 patients
undergoing 16-slice MSCT were evaluated during a
follow-up period of 2 years [32]. As illustrated in
Fig. 3, event rates for all-cause mortality ranged
between 0.3% for patients with none or mild athero-
sclerosis (stenosis \50%) on MSCT to 15% in
patients with mild to moderate left main disease.
Several studies have addressed the incremental
prognostic value of anatomic imaging when used in
additiontomyocardialperfusionimaging(MPI).Inthe
studies by Ramakrishna et al. and Anand et al.,
respectively 835 and 510 patients were enrolled who
underwentbothCSandMPI[33,34].Thecombination
of these techniques resulted in a synergistic prediction
of cardiovascular events. Rozanski and colleagues
assessed the combined use of CS and MPI in a large
cohort of 1,153 asymptomatic patients [35]. Interest-
ingly, in patients with normal myocardial perfusion on
MPI(n = 1,089),theobservationofahighCSwasnot
associated with an increased risk for cardiac death and
myocardial infarction during a mean follow-up of
32 ± 16 months. In contrast, Schenker et al. recently
observed in symptomatic patients that the risk of all-
cause mortality and myocardial infarction increased
withincreasingCS,bothinpatientswithnormalandin
patients with abnormal perfusion on MPI [36]. Simi-
larly, van Werkhoven et al. recently demonstrated that
the information on plaque burden and composition
obtained by MSCT coronary angiography had incre-
mental prognostic value over MPI [37]. Accordingly,
Int J Cardiovasc Imaging (2009) 25:241–254 245
123the precise relative prognostic values of anatomical
and functional techniques remain not fully deﬁned at
present and may highly depend on the patient popu-
lation that is studied. Although their combination may
enhance risk stratiﬁcation, one should realize that it is
at the cost of increased radiation burden. Further
research is required to identify those patients that may
substantially beneﬁt from comprehensive anatomical
and functional assessment. However, recent innova-
tions in MSCT technology and acquisition protocols,
such as prospective ECG-triggering, have resulted in
substantial dose reduction without loss of image
quality [38]. Moreover, Herzog et al. recently demon-
strated that also the high diagnostic accuracy and high
negativepredictivevalueofthetechniqueinparticular,
were maintained atan averageradiation doseas low as
2.1 ± 0.7 mSv (range: 1.0–3.3) [39]. Importantly
these recent developments are currently also being
implemented in hybrid systems and recent data have
conﬁrmed the feasibility of low dose (B10 mSv)
hybrid PET/CT and even SPECT/CT [40, 41].
Developments in imaging of cardiac structures
and function
LV function assessment using MSCT
LV function serves as a valuable prognostic and
diagnostic marker in patients with CAD [42, 43] and
can be evaluated with MSCT. Depending on the
MSCT acquisition technique, retrospective recon-
struction of cardiac images in any tomographic plane
throughout the cardiac cycle is possible. To assess
global LV function, 10 or 20 cine-loops are in general
obtained by reconstructing thick slices (2 mm) in the
short-axis orientation throughout the R–R interval (in
steps of 5 or 10%). Subsequently, end-systolic and -
diastolic phases are determined by selecting the
smallest and largest cross-sectional LV cavity areas.
Specialized software is used for semi-manual or since
more recently fully automatic delineation of the
endocardial borders of the appropriate phases [44].
Based on the Simpson method, end-diastolic and -
systolic volumes are subsequently derived and the LV
ejection fraction (LVEF) is calculated. More recently
also dedicated volumetric algorithms have become
available. These algorithms use the high contrast
between the LV cavity and myocardium to derive LV
volumes following manual or automated deﬁnition of
the mitral valve plane and LV axis.
The feasibility of LV function evaluation with
MSCT has been investigated extensively. Numerous
studies have shown good agreement for the assess-
ment of global LV function between MSCT and 2D-
echocardiography [45, 46]. Good agreement was
demonstrated for LVEF by Wu et al., as determined
by 64-slice MSCT and 2D-echocardiography in 63
patients (r = 0.87, P\0.001) [47]. In addition,
excellent correlations have also been observed
between measurements obtained by MSCT and
magnetic resonance imaging (MRI), which is
regarded as the gold standard for non-invasive
quantiﬁcation of LV function [48–50]. Moreover,
Yamamuro et al. showed that measurements between
MSCT and MRI were more closely related than
Fig. 3 Prognostic value of
MSCT. Cumulative survival
curves in relation to the
extent of atherosclerosis
plaque (as assessed based
on the Duke Prognostic
Coronary Artery Disease
Index). Reprinted with
permission from reference
[32]
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123measurements between 2D-echocardiography and
MRI, suggesting that MSCT may be even more
accurate than 2D-echocardiography in the evaluation
of LV function [51]. This may be explained by the
fact that, while echocardiography relies on a geo-
metrical assumption of two-dimensional images,
MSCT uses true three-dimensional endocardial bor-
der deﬁnition.
In addition to global LV function assessment,
MSCT allows evaluation of regional wall motion by
displaying the images in cine-loop. Previously,
Henneman et al. showed excellent agreement for
regional wall motion between 64-slice MSCT and
2D-echocardiography, with 96% of segments scored
identically on both modalities (kappa = 0.73) [52].
Mahnken et al. assessed regional wall motion using
16-slice MSCT in comparison to cardiac MRI. In line
with other investigations, the investigators observed a
good agreement between the two modalities, with
86% of segments scored identically (k = 0.79) [53].
It is important to realize that with previous standard
MSCT acquisition protocols, LV function measure-
ments couldbeobtainedretrospectivelyfromthesame
data set acquired for coronary angiography. Thus, LV
function could be assessed without the need for
additional acquisitions. Recently, prospective ECG
gating protocols have been introduced. With these
protocols, data are acquired during a small part of the
cardiac cycle. As a result, radiation dose is substan-
tially reduced but assessment of LV function is no
longer possible. Of note, when ECG pulsing or dose-
modulationisapplied,LVfunctioncanstillbereliably
assessed despite the increased noise during systole.
Nevertheless, the radiation dose associated with this
approachremains higherascomparedtowhendataare
acquired prospectively only during diastole. There-
fore, the necessity for LV function analysis should be
carefully considered for each individual patient.
Imaging of pulmonary vein anatomy with MSCT
In addition to assessment of CAD, the role of MSCT
within catheter ablation procedures has increased
substantially. An increasing number of patients
presents with atrial ﬁbrillation and is subsequently
referred for treatment by means of catheter ablation.
Since the aim of this procedure is to electronically
isolate the pulmonary veins, detailed knowledge of
left atrial and pulmonary vein anatomy both prior and
during the procedure is important. Previous studies
have demonstrated that among patients with atrial
ﬁbrillation, a considerable variation in pulmonary
vein anatomy, including the presence of a common
ostium of the pulmonary veins or the presence of
additional pulmonary veins, exists [54]. These ana-
tomical variations can be easily recognized on MSCT
with higher accuracy as compared to other techniques
[55]. In addition, knowledge of variations in anatomy
and size of related structures such as atrial append-
age, roof and septum is important and may facilitate
the catheter ablation procedure [56]. Moreover, close
proximity of surrounding structures such as the
esophagus and the coronary arteries can be identiﬁed
with MSCT beforehand. Based on this information,
the individual ablation strategy may be adapted to
avoid complications such as atrioesophageal ﬁstula
and coronary artery injury.
Extensive effort is currently invested in the
integration of the MSCT images with the electro-
physiological data in order to have accurate electro-
anatomical images available on-line during the cath-
eter ablation procedure. Several studies have
indicated that fusion of these data is indeed feasible
with only minor registration errors (ranging from 1.6
to 2.1 mm on average) [57]. Moreover, preliminary
data indicate that integrated use of MSCT during the
catheter ablation procedure may substantial reduce
procedural and importantly also ﬂuoroscopy times
[58]. In a recent study, Kistler et al. observed a
signiﬁcant reduction in average ﬂuoroscopy time
from 62 ± 26 min using only the electrophysiolog-
ical images to 49 ± 27 min when integrated electro-
anatomical images were available [58]. Also, an
improvement in procedural success was observed.
Thus, detailed anatomical information obtained by
MSCT may be helpful to facilitate catheter ablation
procedures and may have the potential to improve
procedural success as well reducing complications.
However, thus far only small studies are available
and larger, randomized trials are needed to conﬁrm
that integrated use of MSCT will eventually improve
outcome after catheter ablation.
Imaging of mitral and aortic valve anatomy
with MSCT
Although echocardiography remains the cornerstone
in the evaluation of valvular heart disease, recent data
Int J Cardiovasc Imaging (2009) 25:241–254 247
123have demonstrated the feasibility of MSCT to
accurately study mitral and aortic valve anatomy
and function [59–64]. By using multiphase data sets
obtained during ECG gating, the leaﬂet or cusp
motion can be evaluated in cine loop. For this
purpose, ten image data sets are usually reconstructed
at each 10% of the R–R interval similar as described
for the assessment of LV function. For mitral valve
evaluation, perpendicular planes images of the valve
are preferred, whereas for aortic valve study the
cross-sectional image plane perpendicular to the
valve cusps illustrates precisely the morphology of
the valve (Fig. 4).
The opportunity to non-invasively visualize val-
vular anatomy and surrounding structures may be of
particular interest in the setting of percutaneous valve
repair or replacement (PVR) techniques. These
techniques have been recently introduced as an
alternative therapy for those patients ineligible for
surgery due to high perioperative risk, elderly age or
comorbidity [65–67]. Although transesophageal
echocardiography along with ﬂuoroscopy will remain
the most important imaging techniques to guide PVR
procedures, several technical aspects related to these
procedures require an exact, detailed depiction of the
valvular anatomy and morphology to reach the
highest procedural success. In this new clinical ﬁeld,
three-dimensional high-resolution imaging with
MSCT may be of great value.
Particularly, before performing a coronary sinus
annuloplasty, one of the current percutaneous
approaches for mitral valve repair, an exact study
of the anatomical relation between the mitral
annulus and the coronary sinus is required. The
feasibility of this percutaneous procedure depends
on the distance between the coronary sinus and the
mitral annulus, but also, on the anatomical relation
of these two structures with the course of the left
circumﬂex coronary artery (LCx). The left atrial
enlargement and the mitral annular dilatation usually
observed in patients with severe mitral regurgitation
result in an abnormal separation between the
coronary sinus and the mitral annulus. In those
clinical scenarios, the implantation of the device
through the coronary sinus results in inefﬁcient
remodeling of the mitral annulus and unsuccessful
procedure. So far, two studies have investigated the
anatomical relation between the coronary sinus, the
mitral annulus and the LCx using MSCT. Choudre
et al. studied 14 patients with mitral valve prolapse
Fig. 4 Assessment of the
anatomy of cardiac valves
with MSCT. a A sagittal
plane of the left-side valves
with severe calciﬁcation of
both the aortic and mitral
annulus (arrows). The
cross-sectional plane of the
mitral annulus
(b) demonstrates the extent
of calciﬁcation spreading
towards the left ventricular
outﬂow tract (LVOT).
Mixomatous mitral valve
can be also imaged by
MSCT, showing thickened
mitral leaﬂets (c, arrows).
The cross-sectional plane of
the aortic valve
demonstrates the anatomy
of the valve (tricuspid/
bicuspid) and the extent of
calciﬁcation (d)
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123who were scanned with 16- or 40-MSCT, and
observed that the distance between the coronary
sinus and the mitral annulus increased proportionally
with the mitral annular dilatation in the posterolat-
eral location [68]. Furthermore, in 80% of the
patients the LCx crossed between the coronary sinus
and the mitral annulus, indicating the risk of
impingement of the epicardial artery and the
subsequent myocardial infarction. These ﬁndings
were conﬁrmed by Tops and coworkers, who
compared observations with 64-slice MSCT in15
patients with severe mitral regurgitation to 90
patients without [69]. The authors observed a course
of the coronary sinus located superiorly to the mitral
annulus in the majority of the patients (95%), with
an increasing distance in patients with severe mitral
regurgitation as compared to patients without. In
addition, the LCx was located between the coronary
sinus and the mitral annulus in 68% of the patients.
Accordingly, MSCT may become an important
imaging technique to select potential candidates
for percutaneous mitral valve repair.
Similarly, percutaneous aortic valve replacement
has emerged as a potential alternative approach in the
treatment of patients with severe symptomatic aortic
stenosis [70–73]. To assure a high procedural
success-rate, an optimal selection of the potential
candidates is necessary. For this purpose, an exact
aortic annulus sizing and a detailed anatomical
description of the aortic root and the surrounding
structures, including the coronary ostia, are crucial to
avoid complications such as the presence of signif-
icant paravalvular aortic regurgitation or coronary
occlusion by a bulky leaﬂet after device deployment.
In addition, knowledge of the amount of calciﬁcation
and the morphology of the aortic valve (tricuspid or
bicuspid) is also highly relevant. Indeed, excessive
calciﬁcation of the valve or a bicuspid morphology
may result in misdeployment of the device and
higher risk of complications (paravalvular leakage or
Fig. 5 Assessment of the
aortic valve prior to and
after PVR with MSCT.
Before percutaneous aortic
valve replacement, the
distance between the aortic
annulus and the left and
right coronary ostia may be
of great value in order to
estimate the risk of
coronary ostium occlusion
by a bulky leaﬂet (a and b).
After prosthesis
implantation, the optimal
deployment of the device
and the patency of the
coronary ostia can be
assessed by MSCT (c and
d)
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123prosthesis embolization) [74, 75]. Accordingly pre-
operative knowledge of these aspects obtained by
MSCT may inﬂuence the choice of valvular prosthe-
sis type as well as valve replacement strategy. The
feasibility of MSCT in this regard was recently
investigated by Tops et al., who performed an
extensive assessment of the aortic root anatomy
using 64-MSCT in 169 patients, including 19 patients
with aortic stenosis [76]. The main ﬁndings of this
study included an oval-shape of the aortic annulus,
with larger diameter in the coronal images
(26.7 ± 3.9 mm) than in the sagittal images
(24.2 ± 3 mm). In addition, a variable height of the
coronary ostia (Fig. 5) was observed with the length
of the left coronary leaﬂet exceeding the distance
between the annulus and the left coronary ostium in
49% of patients. Accordingly the authors concluded
that MSCT may indeed provide detailed and clini-
cally relevant information on the shape of the aortic
annulus as well as its relation with the ostia of the
coronary arteries. Potentially, MSCT may also be of
value in assessing prosthesis deployment and posi-
tioning after the procedure (Fig. 5). Prospective
studies should address whether assessment with
MSCT may indeed improve selection of potential
candidates for PVR procedures and improve proce-
dural success and outcome.
Summary and conclusions
During the past few years MSCT has rapidly
developed into a versatile non-invasive imaging
modality. While imaging of the coronary arteries to
determine or rule out the presence of CAD will
remain one of the main indications, additional
information on plaque severity and composition can
be obtained. Potentially this particular feature may
provide clinically relevant information with regard to
risk stratiﬁcation. Notably, imaging with MSCT is
not restricted to the coronary arteries as the entire
heart is visualized high resolution. Accordingly,
comprehensive cardiac assessment is possible and
as a result, the technique has a high potential for
several other cardiac applications, including guidance
of interventional procedures such as catheter ablation
in atrial ﬁbrillation or PVR in valvular heart disease.
Importantly, the improvements in image quality and
accuracy have been paralleled by simultaneous
effective dose reduction, broadening acceptance of
this promising imaging modality. Nevertheless, as the
technique is relatively new, only limited data are
currently available. Large prospective studies are
needed to validate these novel applications of MSCT
for use in daily clinical practice.
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